FDA Requests Removal of All Ranitidine Products (Zantac) from …
WEBThe U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.
Zantac Recall | FDA Removal of Zantac (Ranitidine) Products
WEBMay 28, 2024 · The FDA has recalled Zantac, a heartburn medication, and other ranitidine products, because of contamination with NDMA, a chemical that may cause cancer.
The FDA Announces Two More Antacid Recalls Due to Cancer Risk
WEBJan 10, 2020 · On Wednesday, the Food and Drug Administration announced voluntary recalls of prescription forms of ranitidine by two generic drug companies, Appco Pharma and Northwind Pharmaceuticals, bringing...
Statement alerting patients and health care professionals of …
WEBThe U.S. Food and Drug Administration has learned that some ranitidine medicines, including some products commonly known as the brand-name drug Zantac, contain a nitrosamine impurity called N ...
Statement on new testing results, including low levels of impurities …
WEBOver the past several weeks, the FDA has been investigating the detection of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications, commonly known by the brand name...
Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by …
WEBJul 1, 2024 · Lawsuits began piling up after the U.S. Food and Drug Administration in 2020 asked manufacturers to pull the drug off the market over concerns that ranitidine could degrade into a cancer-causing...
FDA Recalls All Ranitidine (Zantac) Products, Citing Increased …
WEBApr 2, 2020 · The FDA has requested all ranitidine (Zantac) products be pulled from the market immediately. The recall includes all prescription and over-the-counter ranitidine drugs as ongoing...
GSK set to face jury trials over heartburn drug Zantac - Financial Times
WEBJun 1, 2024 · The US Food and Drug Administration and the European Medicines Agency recommended suspension of the use of ranitidine products and the FDA asked all manufacturers to withdraw products based on...
Zantac Lawsuit: Status, Eligibility, & Settlements - Drugwatch
WEBSep 3, 2024 · FDA found Zantac’s active ingredient ranitidine contained N-Nitrosodimethylamine (‘NDMA’) — a probable human carcinogen. One plaintiff, using the initials VB to protect her privacy, told Drugwatch that she filed a Zantac lawsuit after she lost her husband to stomach cancer.
GSK shares tumble after Delaware court ruling on Zantac - Financial Times
WEBJun 3, 2024 · GSK shares dropped almost 10 per cent on Monday after a ruling from a Delaware judge left the UK drugmaker exposed to US jury trials over its allegedly carcinogenic heartburn treatment Zantac.
Skip to content